Log in

Relevant bibliographies by topics / Fort Duchesne

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Fort Duchesne'

Author: Grafiati

Published: 4 June 2021

Last updated: 17 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Fort Duchesne.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Fort Duchesne"

1

Mattiello-Sverzut, A., M. Souza, C. Baptista, M. Figueiredo, and R. Alvades. "Ankle-foot orthoses in Duchenne muscular dystrophy." Neuromuscular Disorders 25 (October 2015): S304. http://dx.doi.org/10.1016/j.nmd.2015.06.421.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Timonen, Anne, Michele Lloyd-Puryear, David M. Hougaard, Liisa Meriö, Pauliina Mäkinen, Ville Laitala, Tuukka Pölönen, et al. "Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP® Neonatal Creatine Kinase-MM Kit in a US and Danish Population." International Journal of Neonatal Screening 5, no. 3 (August 27, 2019): 27. http://dx.doi.org/10.3390/ijns5030027.

Full text

Abstract:

Duchenne muscular dystrophy (DMD/Duchenne) is a progressive X-linked disease and is the most common pediatric-onset form of muscular dystrophy, affecting approximately 1:5000 live male births. DNA testing for mutations in the dystrophin gene confirms the diagnosis of this disorder. This study involves assessment of screening newborns for DMD using an immunoassay for muscle-type (MM) creatine kinase (CK) isoform—the GSP Neonatal CK-MM kit. Comparisons were made with CK activity determination by fluorescence measurement. In addition, the study evaluated the effect of gestational age, age of infant at time of sampling and how stable the CK-MM was over time. This assay discriminates well between normal, unaffected and Duchenne affected populations and is suitable for Duchenne newborn screening.

APA, Harvard, Vancouver, ISO, and other styles

3

Jomantiene, Rasa, Robert E. Davis, Ellen L. Dally, John L. Maas, and Joseph D. Postman. "The Distinctive Morphology of `Fragaria multicipita' Is Due to Phytoplasma." HortScience 33, no. 6 (October 1998): 1069–72. http://dx.doi.org/10.21273/hortsci.33.6.1069.

Full text

Abstract:

The rare plant, Fragaria multicipita Fern., was characterized by an unusual vegetative morphology that was long presumed to be suggestive of an ice front relict. While an additional species of Fragaria would be a potential source of genetic diversity for enhancing cultivated strawberry germplasm, evidence now indicates that such potential is not present in F. multicipita. Grafting of F. multicipita to F. chiloensis Duchesne resulted in transmission of a subgroup 16SrVI-B phytoplasma to, and the development of multicipital growth in, F. chiloensis. The results indicated that F. multicipita is a phytoplasma-diseased aberrant growth form of F. virginiana Duchesne and is an unfounded taxon. It is apparent that this plant population offers no unique potential for increasing genetic diversity in cultivated strawberry germplasm, but the phytoplasma may be capable of infecting commercial strawberry.

APA, Harvard, Vancouver, ISO, and other styles

4

Bromwich, W., M. James, C. Stewart, N. Emery, and R. Quinlivan. "Outcomes using ambulatory Ankle Foot Orthoses in Duchenne Muscular Dystrophy." Gait & Posture 36 (June 2012): S94—S95. http://dx.doi.org/10.1016/j.gaitpost.2011.10.342.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Fernandes, Naelka dos Anjos, Denise Caldeira Troise, Francis Meire Fávero, Sissy Veloso Fontes, and Acary Souza Bulle Oliveira. "A Importância das Órteses de Membros Inferiores na Distrofia Muscular de Duchenne." Revista Neurociências 20, no. 4 (December 31, 2012): 584–87. http://dx.doi.org/10.4181/rnc.2012.20.701.4p.

Full text

Abstract:

Introdução. A habilidade motora do paciente com Distrofia Muscular de Duchenne decresce progressivamente e a fisioterapia é fundamental no tratamento destes pacientes para manutenção da força muscular e amplitude de movimento, por meio de alongamentos diários e ortetização. Objetivo. Identificar a importância das principais órteses de membros inferiores utilizadas no tratamento de pacientes com Distrofia Muscular de Duchenne. Método. Foram realizadas buscas eletrônicas nas bases de dados MEDLINE, LILACS, SCIELO a fim de identificar os artigos científicos indexados e publicados de 1979 a 2010. Resultados. Dez artigos foram selecionados. Dos artigos selecionados, um era estudo retrospectivo, oito eram estudos prospectivos, um era um estudo prospectivo randomizado. Os artigos tratavam dos tipos de órteses mais utilizadas no tratamento de pacientes com Distrofia Muscular de Duchenne, e dos benefícios que o uso desses dispositivos proporcionava aos pacientes. Conclusões. A órtese mais utilizada é a Knee-Ankle-Foot (KAFO), a qual é importante para prevenção/minimização de contraturas e deformidades, prolongamento da marcha e ortostatismo dos pacientes.

APA, Harvard, Vancouver, ISO, and other styles

6

DeSandies, Kisha D., and Gabriella Madden. "Philadelphia College of Osteopathic Medicine Examines Embryonic Cells to Find the Origin of Muscles With Image Analysis Software." Microscopy Today 8, no. 7 (September 2000): 34–36. http://dx.doi.org/10.1017/s1551929500054687.

Full text

Abstract:

Tens of thousands of Americans suffer from muscular dystrophy (MD), a disease that gradually deteriorates a person's skeletal muscle. While there is no effective cure, scientists know MD is caused by a genetic defect and are searching for treatments that will stop or retard the deterioration of muscle. In June, American and British researchers announced the success of a long-term treatment that repairs the genetic defect in Duchenne muscular dystrophy, the most common childhood form of MD.Last fall, these researchers injected a short strand of nucleic acid into the shin muscle of a six-week old golden retriever - which had a genetic defect that leads to Duchenne MD in dogs - in order to maintain normal levels of dystrophin, the muscle protein missing in Duchenne MD. Their goal was for the nucleic acid to trigger the dog's system to correct the genetic defect. Eleven months later, the injected muscle continues to show normal levels of dystrophin.

APA, Harvard, Vancouver, ISO, and other styles

7

Winarno, Soelatin, Indrawarman Indrawarman, Sabdo Waloejo, and Lydia Kristianti. "Progressive Muscular Dystrophy (Duchenne Type) (Case Report)." Paediatrica Indonesiana 16, no. 9-10 (September 17, 2019): 361–4. http://dx.doi.org/10.14238/pi16.9-10.1976.361-4.

Full text

Abstract:

Clinical findings of two brothers suffering from progressive muscular dystrophy pseudohypertrophic type according to Duchenne are reported. Literatures dealing with its clinical classification, biochemical disturbances, hypotheses of the pathogenesis, management of treatment, mode of action of A.T.P. and the pedigree have been briefly reported. Progressive Muscular Dystrophy is a progressive disease affecting voluntary muscles; It is characterized by a decreased strength in the affected muscles with rapid or slow gradual progression. About 45% of the patients gave a history that at least another member of the family is affected by the disease. Pseudohypertrophic form (Duchenne type) is usually inherited as a recessive factor, often sexlinked.

APA, Harvard, Vancouver, ISO, and other styles

8

Culligan, Kevin, and Kay Ohlendieck. "Diversity of the Brain Dystrophin-Glycoprotein Complex." Journal of Biomedicine and Biotechnology 2, no. 1 (2002): 31–36. http://dx.doi.org/10.1155/s1110724302000347.

Full text

Abstract:

Duchenne muscular dystrophy (DMD), the most common inherited neuromuscular disorder, is characterized by progressive muscle wasting and weakness. One third of Duchenne patients suffer a moderate to severe, nonprogressive form of mental retardation. Mutations in the DMD gene are thought to be responsible, with the shorter isoforms of dystrophin implicated in its molecular brain pathogenesis. It is becoming clear that region-specific variations in dystrophin isoforms delegate the composition of the dystrophin-glycoprotein complex in brain, and hence, the function of the specific membrane assembly. Here we summarize the recent advances in the understanding of brain dystrophin, dystrophin-related proteins and dystrophin-associated proteins.

APA, Harvard, Vancouver, ISO, and other styles

9

Mackie, Gregory. "“THE MODERN IDEA UNDER AN ANTIQUE FORM”: AESTHETICISM AND THEATRICAL ARCHAEOLOGY IN OSCAR WILDE'S DUCHESS OF PADUA." Theatre Survey 53, no. 2 (August 28, 2012): 219–39. http://dx.doi.org/10.1017/s0040557412000063.

Full text

Abstract:

During his final years in exile, Oscar Wilde derived as much income as he could from selling the rights to his as-yet-unpublished writings. Although at that time he was as pragmatic in his approach to the business of authorship as he had been during the height of his dramatic career in the early 1890s, Wilde nonetheless resisted publishing one of his earliest plays, the 1883 blank-verse tragedy The Duchess of Padua. In an 1898 letter to Robert Ross, Wilde noted of the play (which was finally produced in 1891) that “The Duchess is unfit for publication—the only one of my works that comes under that category. But there are some good lines in it.” Wilde had not always had such a dim view of his second completed play. Indeed, he once promoted it as “the masterpiece of all my literary work, the chef-d'oeuvre of my youth” and had worked hard to see it produced. Literary history, however, has tended to concur with Wilde's more mature assessment of the play's artistic merits. Katharine Worth, one of the few critics to assess the play in detail, suggests that it “is the one completed play of Wilde's which can scarcely be imagined in a modern performance.” Josephine M. Guy and Ian Small place the play among a group of early works by Wilde that “have been judged by modern critics to be failures.” According to their view, The Duchess “is seen as an embarrassment.” This essay instead regards The Duchess as an uneven experiment in both staging aestheticism and late Victorian theatrical “archaeology,” a practice that sought to mount historical dramas with as much accuracy and precision in costume and design as possible. In a letter to Mary Anderson, the American actress whom he hoped would star in the play, Wilde contextualized the spectacle to which he aspired in The Duchess: “the essence of art is to produce the modern idea under an antique form.”

APA, Harvard, Vancouver, ISO, and other styles

10

Leitch, Khristinn Kellie, Naweed Raza, Doug Biggar, Derek Stephen, James G. Wright, and Benjamin Alman. "Should Foot Surgery Be Performed for Children With Duchenne Muscular Dystrophy?" Journal of Pediatric Orthopaedics 25, no. 1 (January 2005): 95–97. http://dx.doi.org/10.1097/00004694-200501000-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Fort Duchesne"

1

Huetter, Robert A. "A History of Fort Duchesne, Utah, and the Role of its First Commanding Officer, Frederick W. Benteen." Diss., CLICK HERE for online access, 1990. http://patriot.lib.byu.edu/u?/MTGM,14001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Koppaka, Sisir. "Imaging biomarkers for Duchenne muscular dystrophy." Thesis, Massachusetts Institute of Technology, 2015. http://hdl.handle.net/1721.1/106959.

Full text

Abstract:

Thesis: S.M., Massachusetts Institute of Technology, School of Engineering, Center for Computational Engineering, Computation for Design and Optimization Program, 2015.
Cataloged from PDF version of thesis.
Includes bibliographical references (pages 75-78).
Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of childhood and affects 1 in 3600 male births. The disease is caused by mutations in the dystrophin gene leading to progressive muscle weakness which ultimately results in death due to respiratory and cardiac failure. Accurate, practical, and painless tests to diagnose DMD and measure disease progression are needed in order to test the effectiveness of new therapies. Current clinical outcome measures such as the sixminute walk test and North Star Ambulatory Assessment (NSAA) can be subjective and limited by the patient's degree of effort and cannot be accurately performed in the very young or severely affected older patients. We propose the use of image-based biomarkers with suitable machine learning algorithms instead. We find that force-controlled (precise acquisition at a certain force) and force-correlated (acquisition over a force sweep) ultrasound helps to reduce variability in the imaging process. We show that there is a high degree of inter-operator and intra-operator reliability with this integrated hardware-software setup. We also discuss how other imaging biomarkers, segmentation algorithms to target specific subregions, and better machine learning techniques may provide a boost to the performance reported. Optimizing the ultrasound image acquisition process by maximizing the peak discriminatory power of the images vis-à-vis force applied at the contact force is also discussed. The techniques presented here have the potential for providing a reliable and non-invasive method to discriminate, and eventually track the progression of DMD in patients.
by Sisir Koppaka.
S.M.

APA, Harvard, Vancouver, ISO, and other styles

3

Rabinowitz, Adam Howard. "Antisense therapies for Duchenne muscular dystrophy." Thesis, Imperial College London, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444590.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Wakefield, Philip M. "Gene therapy for duchenne muscular dystrophy." Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.365743.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Taktak, Diane M. "A lightweight modular knee-ankle-foot orthosis for Duchenne muscular dystrophy." Thesis, University of Salford, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.261992.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Al, Majathoub Mohannad. "Development of cryopreservation techniques for strawberry ((Fragaria x ananassa Duchesne)." Thesis, University of Derby, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.427603.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Dunant, Patrick. "Strategies for Molecular Therapy of Duchenne Muscular Dystrophy." Diss., lmu, 2003. http://nbn-resolving.de/urn:nbn:de:bvb:19-12429.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Buser, Karen N. Kamiri. "Parental Attitudes Regarding Newborn Screening for Duchenne Muscular Dystrophy." Case Western Reserve University School of Graduate Studies / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=case1307627473.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Jara, Peña Enoc Efer. "Evaluación de soluciones hidropónicas para la producción de "fresa" Fragaria x ananassa Duchesne cv. Chandler." Bachelor's thesis, Universidad Nacional Mayor de San Marcos, 1999. https://hdl.handle.net/20.500.12672/6270.

Full text

Abstract:

El documento digital no refiere asesor
La fresa (Fragaria x ananassa Duchesne) es un cultivo de importancia económica que presenta serios problemas de enfermedades con lo que la calidad sanitaria y comercial del fruto baja e implica fuertes pérdidas económicas en su producción. Esta situación puede ser mejorada con plantas que presenten un buen desarrollo, bajo sistemas que mejoren su calidad sanitaria y productividad. Con esta finalidad en el presente trabajo se evaluó a 2 formulaciones de soluciones nutritivas durante la etapa vegetativa y 3 formulaciones durante la etapa fructificación de plantas de la variedad Chandler obtenidas a partir de cultivo in vitro, realizándose el experimento bajo condiciones de "invernadero" usando un sistema hidropónico en grava muy fina en Carabayllo al norte de Lima durante los meses de Diciembre de 1996 a Agosto de 1997. Durante el periodo de cultivo la temperatura fluctuó entre 14.1 °C y 25.6 °C. Se realizaron muestreos destructivos a los 60, 90, 160, 190 y 220 días después de iniciado el tratamiento (ddt) para evaluar crecimiento, desarrollo y análisis químico de los órganos de la planta; adicionalmente en la etapa reproductiva de la planta se evaluaron número de flores, número, peso y contenido de azúcares reductores en los frutos. No se encontró diferencias significativas entre los tratamientos en la etapa vegetativa pero sí en la etapa reproductiva al evaluar la altura de la planta, número de flores, porcentaje de azúcares reductores de los frutos, número y peso de los frutos en la cosecha Tampoco se encontró diferencias significativas en el porcentaje de Nitrógeno, Fósforo, Potasio, Calcio, Magnesio y Hierro. Combinaciones de 200:40:300 ppm de N:P:K en la etapa reproductiva favorecieron el mayor rendimiento en la planta.
Tesis

APA, Harvard, Vancouver, ISO, and other styles

10

Jara, Peña Enoc Efer. "Evaluación de soluciones hidropónicas para la producción de "fresa" Fragaria x ananassa Duchesne cv. Chandler." Bachelor's thesis, Universidad Nacional Mayor de San Marcos, 1999. http://cybertesis.unmsm.edu.pe/handle/cybertesis/6270.

Full text

Abstract:

La fresa (Fragaria x ananassa Duchesne) es un cultivo de importancia económica que presenta serios problemas de enfermedades con lo que la calidad sanitaria y comercial del fruto baja e implica fuertes pérdidas económicas en su producción. Esta situación puede ser mejorada con plantas que presenten un buen desarrollo, bajo sistemas que mejoren su calidad sanitaria y productividad. Con esta finalidad en el presente trabajo se evaluó a 2 formulaciones de soluciones nutritivas durante la etapa vegetativa y 3 formulaciones durante la etapa fructificación de plantas de la variedad Chandler obtenidas a partir de cultivo in vitro, realizándose el experimento bajo condiciones de "invernadero" usando un sistema hidropónico en grava muy fina en Carabayllo al norte de Lima durante los meses de Diciembre de 1996 a Agosto de 1997. Durante el periodo de cultivo la temperatura fluctuó entre 14.1 °C y 25.6 °C. Se realizaron muestreos destructivos a los 60, 90, 160, 190 y 220 días después de iniciado el tratamiento (ddt) para evaluar crecimiento, desarrollo y análisis químico de los órganos de la planta; adicionalmente en la etapa reproductiva de la planta se evaluaron número de flores, número, peso y contenido de azúcares reductores en los frutos. No se encontró diferencias significativas entre los tratamientos en la etapa vegetativa pero sí en la etapa reproductiva al evaluar la altura de la planta, número de flores, porcentaje de azúcares reductores de los frutos, número y peso de los frutos en la cosecha Tampoco se encontró diferencias significativas en el porcentaje de Nitrógeno, Fósforo, Potasio, Calcio, Magnesio y Hierro. Combinaciones de 200:40:300 ppm de N:P:K en la etapa reproductiva favorecieron el mayor rendimiento en la planta.
Tesis

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Fort Duchesne"

1

Parker, Virginia Carlson. Indian summers: A memoir of Fort Duchesne, 1925-1935. Logan, Utah: V.C. Parker, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Steve, Beshwaty, ed. Edmond et Amandine. Saint-Lambert, Québec: Dominique et compagnie, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Margaret Cavendish: Gender, genre, exile. Manchester, UK: Manchester University Press, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Occupational Therapy and Duchenne Muscular Dystrophy. Wiley, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Tester, Claire, Joy Blakeney, Alex Howarth, Hether McAndrew, and Kate Stone. Occupational Therapy and Duchenne Muscular Dystrophy. Wiley & Sons, Incorporated, John, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kate, Stone, ed. Occupational therapy and Duchenne muscular dystrophy. Chichester, West Sussex, England: John Wiley & Sons, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Firth, Helen V., Jane A. Hurst, and Judith G. Hall. Appendix. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780192628961.003.0204.

Full text

Abstract:

Bayes’ theorem 646Behavioural pattern profile (Shalev and Hall 2004) 648Carrier frequency and carrier testing for autosomal recessive disorders 650Centile charts for boys height and weight 652Centile charts for girls height and weight 656Centile charts for occipital-frontal circumference (OFC) 660CK (Creatine kinase) levels in carriers of Duchenne muscular dystrophy (DMD) ...

APA, Harvard, Vancouver, ISO, and other styles

8

Nageshwaran, Sathiji, Heather C. Wilson, Anthony Dickenson, and David Ledingham. Disorders of muscle and neuromuscular junction. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199664368.003.0008.

Full text

Abstract:

This chapter discusses the clinical features and evidence base for the pharmacological treatment of muscular disorders (inflammatory myopathies: polymyositis, dermatomyositis, and inclusion body myositis), mitochondrial myopathies, Duchenne muscular dystrophy (DMD), myotonic dystrophy, inherited neuromuscular channelopathies, non-dystrophic myotonias (myotonia congenita, paramyotonia congenita), periodic paralyses, acquired neuromyotonia (Isaac syndrome and Morvan syndrome), stiff person syndrome, and disorders of the neuromuscular junction (myasthenia gravis (MG), myasthenic crisis, and Lambert–Eaton myasthenic syndrome (LEMS).

APA, Harvard, Vancouver, ISO, and other styles

9

Kreeger, Renee, and James P. Spaeth. Muscular Dystrophy. Edited by Erin S. Williams, Olutoyin A. Olutoye, Catherine P. Seipel, and Titilopemi A. O. Aina. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190678333.003.0058.

Full text

Abstract:

Duchenne muscular dystrophy (DMD) is a complex disease characterized by multiple physiologic perturbations, progressively leading to cardiomyopathy, respiratory failure, and, eventually, death. Patients with DMD create unique challenges for the anesthesia team, including management of a difficult airway, avoidance of volatile anesthetics and succinylcholine, the need for respiratory support, and discussion of advance directives. A thorough and multidisciplinary collaborative approach must be utilized in the care of these patients for the entire perioperative period. This chapter uses a case example of a 17-year-old boy with DMD who presents for preoperative anesthesia consultation in anticipation of percutaneous endoscopic gastrostomy tube placement.

APA, Harvard, Vancouver, ISO, and other styles

10

Kreeger, Renee Nierman, and James P. Spaeth. Muscular Dystrophy. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199764495.003.0063.

Full text

Abstract:

Gastrostomy tube placement is typically a routine surgical procedure with little concern for morbidity and mortality. However, in patients with Duchenne muscular dystrophy (DMD), this is not the case. Patients with DMD present a unique clinical dilemma since they often do not require gastrostomy tube placement until their physical status has deteriorated to the point that they have respiratory insufficiency or failure and clinically significant cardiomyopathy. An understanding of the pathophysiology of this disorder and a proactive approach to perioperative management are important to ensure a positive patient outcome.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Fort Duchesne"

1

Wymer, Rowland. "The Duchess of Malfi." In Webster and Ford, 52–71. London: Macmillan Education UK, 1995. http://dx.doi.org/10.1007/978-1-349-23853-8_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Davidson, Zoe E., Greg Rodden, Davi A. G. Mázala, Cynthia Moore, Carol Papillon, Angela J. Hasemann, Helen Truby, and Robert W. Grange. "Practical Nutrition Guidelines for Individuals with Duchenne Muscular Dystrophy." In Regenerative Medicine for Degenerative Muscle Diseases, 225–79. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-3228-3_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Guan, Xuan, David Mack, and Martin K. Childers. "Patient-Derived Induced Pluripotent Stem Cells Provide a Regenerative Medicine Platform for Duchenne Muscular Dystrophy Heart Failure." In Regenerative Medicine for Degenerative Muscle Diseases, 129–55. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-3228-3_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Tursi, Alessandra, and Giuseppe Mincolelli. "Design for People Affected by Duchenne Muscular Dystrophy. Proposal of a New Type of Ankle Foot Orthosis [AFO] Based on 3D Indirect Survey and 3D Printing." In Advances in Intelligent Systems and Computing, 81–86. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-41962-6_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Eagle, Michelle. "Duchenne muscular dystrophy." In Physiotherapy for Children, 242–62. Elsevier, 2007. http://dx.doi.org/10.1016/b978-0-7506-8886-4.50019-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Paris, Harry S. "Biographie d’Antoine Nicolas Duchesne." In The drawings of Antoine Nicolas Duchesne for his Natural History of the Gourds, 21–22. Publications scientifiques du Muséum, 2007. http://dx.doi.org/10.4000/books.mnhn.5161.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hall, David M. B., and David Elliman. "Laboratory and radiological screening tests." In Health for all Children, 192–200. Oxford University Press, 2006. http://dx.doi.org/10.1093/med/9780198570844.003.0009.

Full text

Abstract:

Chapter 9 cover phenylketonuria and hypothyroidism, other metabolic disorders, cystic fibrosis, Duchenne muscular dystrophy, urine analysis and urine infections, reflux, haemoglobinopathies, liver disease in infancy, hypercholesterolaemia, lead poisoning, neuroblastoma, and coeliac disease.

APA, Harvard, Vancouver, ISO, and other styles

8

Paris, Harry S. "Biography of Antoine Nicolas Duchesne." In The drawings of Antoine Nicolas Duchesne for his Natural History of the Gourds, 19–20. Publications scientifiques du Muséum, 2007. http://dx.doi.org/10.4000/books.mnhn.5158.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Georgievna Sokolova, Mariia, and Ekaterina Valentinovna Lopatina. "Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy." In Muscular Dystrophy - Research Updates and Therapeutic Strategies. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.92543.

Full text

Abstract:

Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease; it occurs due to a mutation in the dystrophin protein gene; as a result, the protein is not synthesized and muscle tissue dies. On the one hand, we can say that this disease has been sufficiently studied; however, it is still incurable, and there are a number of issues remaining unclear in terms of the development of progressive dementia as a symptom in 30% of patients with Duchenne muscular dystrophy. We conducted a study at the intersection of molecular genetic, neurological, and enzyme-linked immunosorbent patients’ blood tests and experiments in organotypic culture, which allowed us to determine important points in the development of cognitive disorders in patients with Duchenne muscular dystrophy and identify a significant effect of growth factor concentration in patients. The chapter will present data on neurotrophic regulation in patients with Duchenne muscular dystrophy (by the best-studied neurotrophins), demonstrate special aspects of neuron-myocyte interaction, and broaden the understanding of the role of apoptosis and synthase proteins in the development of this disease. We would like to highlight the importance of prognostic criteria for the development of cognitive impairment and possible therapeutic measures to prevent progressive dementia

APA, Harvard, Vancouver, ISO, and other styles

10

Paris, Harry S. "Remarques générales de Duchesne sur les pépons." In The drawings of Antoine Nicolas Duchesne for his Natural History of the Gourds, 73–76. Publications scientifiques du Muséum, 2007. http://dx.doi.org/10.4000/books.mnhn.5203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Fort Duchesne"

1

Cassino, Theresa R., Masaho Okada, Lauren Drowley, Johnny Huard, and Philip R. LeDuc. "Mechanical Stimulation Improves Muscle-Derived Stem Cell Transplantation for Cardiac Repair." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192941.

Full text

Abstract:

Muscle-derived stem cells (MDSCs) have been successfully transplanted into both skeletal (1) and cardiac muscle (2) of dystrophin-deficient (mdx) mice, and show potential for improving cardiac and skeletal dysfunction in diseases like Duchenne muscular dystrophy (DMD). Our previous study explored the regeneration of dystrophin-expressing myocytes following MDSC transplantation into environments with distinct blood flow and chemical/mechanical stimulation attributes. After MDSC transplantation within left ventricular myocardium and gastrocnemius (GN) muscles of the same mdx mice, significantly more dystrophin-positive fibers were found within the myocardium than in the GN. We hypothesized that the differences in mechanical loading of the two environments influenced the transplantation and explored whether using MDSCs exposed to mechanical stimulation prior to transplantation could improve transplantation. Our study shows increased engraftment into the heart and GN muscle for cells pretreated with mechanical stretch for 24 hours. This increase was significant for transplantation into the heart. These studies have implications in a variety of applications including mechanotransduction, stem cell biology, and Duchenne muscular dystrophy.

APA, Harvard, Vancouver, ISO, and other styles

2

Janisch, Maria, Silke Nolte-Buchholtz, and Maja von der Hagen. "FV 871. Pediatric Palliative Care of Duchenne Muscular Dystrophy in Germany." In Abstracts of the 44th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1675922.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Regensburger, Adrian P., Lina Fonteyne, Jörg Jüngert, Matthias Qurashi, Markus F. Neurath, Nikolai Klymiuk, Elisabeth Kemter, et al. "New Non-invasive Biomarkers in Duchenne Muscular Dystrophy: Translational Molecular Imaging with Multispectral Optoacoustic Tomography." In Abstracts of the 45th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1698173.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Schorling, David, Cornelia Müller, Astrid Pechmann, Sabine Borell, Thorsten Langer, Simone Thiele, Maggie Walter, Barbara Zieger, and Janbernd Kirschner. "FV 880. Disorders of Coagulation in Duchenne Muscular Dystrophy?—Results of a Registry-Based Online Questionnaire." In Abstracts of the 44th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1675908.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yi, Chunzhi, Ningling Ma, Chifu Yang, Hao Guo, Jiahong Han, Hefu Gao, Xiang Li, and Feng Jiang. "A Novel Automatic Diagnosis Based Physical Therapy for Duchenne Muscular Dystrophy Children." In 2018 IEEE Third International Conference on Data Science in Cyberspace (DSC). IEEE, 2018. http://dx.doi.org/10.1109/dsc.2018.00088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Cassino, Theresa R., Masaho Okada, Lauren M. Drowley, Joseph Feduska, Johnny Huard, and Philip R. LeDuc. "Using Mechanical Environment to Enhance Stem Cell Transplantation in Muscle Regeneration." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176545.

Full text

Abstract:

Muscle-derived stem cell (MDSC) transplantation has shown potential as a therapy for cardiac and skeletal muscle dysfunction in diseases such as Duchenne muscular dystrophy (DMD). In this study we explore mechanical environment and its effects on MDSCs engraftment into cardiac and skeletal muscle in mdx mice and neoangiogenesis within the engraftment area. We first looked at transplantation of the same number of MDSCs into the heart and gastrocnemius (GN) muscle of dystrophic mice and the resulting dystrophin expression. We then explored neoangiogenesis within the engraftments through quantification of CD31 positive microvessels. This study is important to aid in determining the in vivo environmental factors leading to large graft size which may aid in determining optimum transplantation conditions for muscle repair.

APA, Harvard, Vancouver, ISO, and other styles

7

Cirak, S., H. Wang, J. Novak, TA Partridge, and U. Akpulat. "A scientific approach to improve Morpholino-based Exon-Skipping therapy for Duchenne Muscular Dystrophy." In 24. Kongress des Medizinisch-Wissenschaftlichen Beirates der Deutschen Gesellschaft für Muskelkranke (DGM) e.V. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1684966.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Nohavicka, L., V. Nesbitt, S. Chandratre, and JE Harrop. "G520(P) Triggers for referral to hospice care in children with duchenne muscular dystrophy." In Royal College of Paediatrics and Child Health, Abstracts of the Annual Conference, 24–26 May 2017, ICC, Birmingham. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313087.512.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Müller-York, André, Joel Iff, Charles Gerrits, Gautam Sajeev, James Signorovitch, Edward Tuttle, Erica Birk, et al. "Eteplirsen Delays Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy Compared With Patients Receiving Standard of Care." In Abstracts of the 45th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1698172.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Webb, Casey, Michael Jensen, Bart J. Kowallis, Eric H. Christiansen, and Douglas Sprinkel. "STRATIGRAPHIC RELATIONSHIPS WITHIN THE DUCHESNE RIVER FORMATION AND BISHOP CONGLOMERATE: CONCLUSIONS FOR MAPPING THE VERNAL NW QUADRANGLE, UT." In Rocky Mountain Section - 69th Annual Meeting - 2017. Geological Society of America, 2017. http://dx.doi.org/10.1130/abs/2017rm-293190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Fort Duchesne"

1

Cnaan, Avital. CINRG: Infrastructure for Clinical Trials in Duchenne Dystrophy. Fort Belvoir, VA: Defense Technical Information Center, September 2012. http://dx.doi.org/10.21236/ada567633.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cnaan, Avital. CINRG: Infrastructure for Clinical Trials in Duchenne Dystrophy. Fort Belvoir, VA: Defense Technical Information Center, September 2013. http://dx.doi.org/10.21236/ada599521.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Martin, Paul T. Translational Studies of GALGT2 Gene Therapy for Duchenne Muscular Dystrophy. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada613577.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Martin, Paul T. Translational Studies of GALGT2 Gene Therapy for Duchenne Muscular Dystrophy. Fort Belvoir, VA: Defense Technical Information Center, October 2013. http://dx.doi.org/10.21236/ada598203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Byrne, Barry J. Advanced Gene Therapy for Treatment of Cardiomyopathy and Respiratory Insufficiency in Duchenne Muscular Dystrophy. Fort Belvoir, VA: Defense Technical Information Center, September 2014. http://dx.doi.org/10.21236/ada613171.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!